标题
Blood-brain barrier, cytotoxic chemotherapies and glioblastoma
作者
关键词
-
出版物
Expert Review of Neurotherapeutics
Volume 16, Issue 11, Pages 1285-1300
出版商
Informa UK Limited
发表日期
2016-06-17
DOI
10.1080/14737175.2016.1202761
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ultrasound-induced opening of the blood-brain barrier to enhance temozolomide and irinotecan delivery: an experimental study in rabbits
- (2016) Kevin Beccaria et al. JOURNAL OF NEUROSURGERY
- Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
- (2015) Jason M. Lajoie et al. Annual Review of Pharmacology and Toxicology
- Enhanced brain distribution of carboplatin in a primate model after blood–brain barrier disruption using an implantable ultrasound device
- (2015) Lauriane Goldwirt et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Heterogeneous vascular permeability and alternative diffusion barrier in sensory circumventricular organs of adult mouse brain
- (2015) Shoko Morita et al. CELL AND TISSUE RESEARCH
- The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma
- (2015) J. L. Pokorny et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature
- (2015) Megan O. Jacus et al. CLINICAL PHARMACOKINETICS
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer-treatment-induced neurotoxicity—focus on newer treatments
- (2015) Jacqueline B. Stone et al. Nature Reviews Clinical Oncology
- The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes
- (2015) Azeem A. Rehman et al. Neurosurgical Focus
- Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma
- (2015) Fang Zhang et al. Drug Design Development and Therapy
- Neurosurgical Techniques for Disruption of the Blood–Brain Barrier for Glioblastoma Treatment
- (2015) Analiz Rodriguez et al. Pharmaceutics
- Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation
- (2014) J J M A Hendrikx et al. BRITISH JOURNAL OF CANCER
- Irinotecan and temozolomide brain distribution: a focus on ABCB1
- (2014) Lauriane Goldwirt et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma
- (2014) Neil U. Barua et al. DRUG DELIVERY
- Enhanced Doxorubicin Delivery to the Brain Administered Through Glutathione PEGylated Liposomal Doxorubicin (2B3-101) as Compared with Generic Caelyx,®/Doxil®—A Cerebral Open Flow Microperfusion Pilot Study
- (2014) Thomas Birngruber et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
- (2014) Pieter J. Gaillard et al. PLoS One
- Gliomas and the vascular fragility of the blood brain barrier
- (2014) Luiz Gustavo Dubois et al. Frontiers in Cellular Neuroscience
- SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery
- (2013) Ching-Hsiang Fan et al. BIOMATERIALS
- Adjunctive use of verapamil in patients with refractory temporal lobe epilepsy: A pilot study
- (2013) Ali A. Asadi-Pooya et al. EPILEPSY & BEHAVIOR
- Improving the prediction of drug disposition in the brain
- (2013) Kiril Lanevskij et al. Expert Opinion on Drug Metabolism & Toxicology
- Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
- (2013) Terri S. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain
- (2013) Fanny Langlet et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Transporters of the blood–brain and blood–CSF interfaces in development and in the adult
- (2013) Norman R. Saunders et al. MOLECULAR ASPECTS OF MEDICINE
- Focused Ultrasound-Induced Blood–Brain Barrier Opening to Enhance Temozolomide Delivery for Glioblastoma Treatment: A Preclinical Study
- (2013) Kuo-Chen Wei et al. PLoS One
- Devices for overcoming biological barriers: The use of physical forces to disrupt the barriers
- (2012) Samir Mitragotri ADVANCED DRUG DELIVERY REVIEWS
- The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model
- (2012) Fahima Dilnawaz et al. BIOMATERIALS
- Temporary Disruption of the Blood-Brain Barrier by Use of Ultrasound and Microbubbles: Safety and Efficacy Evaluation in Rhesus Macaques
- (2012) N. McDannold et al. CANCER RESEARCH
- Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma
- (2012) M. Nagane et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- The disturbed blood–brain barrier in human glioblastoma
- (2012) Hartwig Wolburg et al. MOLECULAR ASPECTS OF MEDICINE
- Orally Bioavailable Tubulin Antagonists for Paclitaxel-Refractory Cancer
- (2012) Chien-Ming Li et al. PHARMACEUTICAL RESEARCH
- 7.0-T Magnetic Resonance Imaging Characterization of Acute Blood-Brain-Barrier Disruption Achieved with Intracranial Irreversible Electroporation
- (2012) Paulo A. Garcia et al. PLoS One
- Bevacizumab Attenuates VEGF-Induced Angiogenesis and Vascular Malformations in the Adult Mouse Brain
- (2012) Espen J. Walker et al. STROKE
- The circumventricular organs of the brain: conspicuity on clinical 3T MRI and a review of functional anatomy
- (2012) Avril Horsburgh et al. SURGICAL AND RADIOLOGIC ANATOMY
- ABC Transporters in the CNS – An Inventory
- (2011) A. M.S. Hartz et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Morphine facilitates doxorubicin penetration in the central nervous system: a new prospect for therapy of brain tumors
- (2011) Iacopo Sardi JOURNAL OF NEURO-ONCOLOGY
- Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
- (2011) Yasuo Uchida et al. JOURNAL OF NEUROCHEMISTRY
- In Vitro Blood–Brain Barrier Models: Current and Perspective Technologies
- (2011) Pooja Naik et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support
- (2011) Elsa Pennese et al. LEUKEMIA & LYMPHOMA
- Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
- (2011) Ramzi Shawahna et al. MOLECULAR PHARMACEUTICS
- Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of Topotecan
- (2011) Jeffrey N. Bruce et al. NEUROSURGERY
- Electromagnetic fields and the blood–brain barrier
- (2010) Rianne Stam BRAIN RESEARCH REVIEWS
- Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
- (2010) K A van Nifterik et al. BRITISH JOURNAL OF CANCER
- Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors
- (2010) Robert J. Morgan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy
- (2010) Shailendra Joshi et al. JOURNAL OF NEURO-ONCOLOGY
- Transnasal Delivery of Methotrexate to Brain Tumors in Rats: A New Strategy for Brain Tumor Chemotherapy
- (2010) Tomotaka Shingaki et al. MOLECULAR PHARMACEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Transcranial Magnetic Resonance Imaging– Guided Focused Ultrasound Surgery of Brain Tumors
- (2010) Nathan McDannold et al. NEUROSURGERY
- OncoGel (ReGel/paclitaxel) — Clinical applications for a novel paclitaxel delivery system
- (2009) Nancy L. Elstad et al. ADVANCED DRUG DELIVERY REVIEWS
- Glioma-induced remodeling of the neurovascular unit
- (2009) Jisook Lee et al. BRAIN RESEARCH
- Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates
- (2009) Shana Jacobs et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Neuropharmacokinetics of Temozolomide in Patients with Resectable Brain Tumors: Potential Implications for the Current Approach to Chemoradiation
- (2009) J. Portnow et al. CLINICAL CANCER RESEARCH
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
- (2009) Gregor Dresemann et al. JOURNAL OF NEURO-ONCOLOGY
- Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection
- (2009) Umar Akbar et al. JOURNAL OF NEURO-ONCOLOGY
- Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human
- (2009) Mark S. Warren et al. PHARMACOLOGICAL RESEARCH
- Anatomy and Imaging of the Normal Meninges
- (2009) Neel Patel et al. SEMINARS IN ULTRASOUND CT AND MRI
- Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer
- (2008) J. Sigmond et al. ANNALS OF ONCOLOGY
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma
- (2008) Maria Grazia Fabrini et al. JOURNAL OF NEURO-ONCOLOGY
- Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model
- (2008) Qingyu Zhou et al. NEURO-ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started